QualityStocksNewsBreaks – BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) to Present Bria-IMT Clinical Data at San Antonio Breast Cancer Symposium
BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT), a biotechnology company developing targeted, safe treatment options for cancer, this morning announced that its Bria-IMT will be featured in a poster session during this year’s San Antonio Breast Cancer Symposium (“SABCS”), to be held December 4-8, 2018, in San Antonio, Texas. The poster highlights data on Bria-IMT’s use as a monotherapy demonstrating positive proof-of-concept, as well as an initial safety and tolerability assessment for its use in combination with pembrolizumab [KEYTRUDA - manufactured by Merck & Co., Inc. (NYSE: MRK)] for advanced breast cancer. Thomas Jefferson University assistant professor of medical oncology…